Home > Healthcare > Healthcare IT > Health Services > AI in Oncology Market

AI in Oncology Market Share

Report ID: GMI8547
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

AI In Oncology Market Share

The AI in oncology industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

AI In Oncology Market Companies

Some of the eminent market participants operating in the AI in oncology industry include:

Azra AI.
ConcertAI.
Digital Diagnostics Inc.
GE HealthCare Technologies Inc.
International Business Machines Corporation
Intel Corporation
Median Technologies SA
NVIDIA Corporation
PathAI, Inc.
Siemens Healthineers AG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The Global AI in oncology industry was valued at around USD 1.9 billion in 2023 and is estimated to reach over USD 17.9 billion by 2032, driven by the increasing prevalence of cancer.

Diagnostics application segment held a market size of USD 341.4 million in 2023 and is expected to grow substantially through 2032, as AI oncology excel at detecting tumors in their earliest stages by analyzing various medical imaging scans including mammograms, CT scanner, and MRI systems.

North America AI in oncology industry accounted for USD 758.1 million in 2023 and is predicted to witness substantial growth over 2024 and 2032, owing to its advanced healthcare infrastructure, including state-of-the-art hospitals, research institutions, and medical facilities.

Azra AI., ConcertAI., Digital Diagnostics Inc., GE HealthCare Technologies Inc., International Business Machines Corporation, Intel Corporation, Median Technologies SA, NVIDIA Corporation, PathAI, Inc., Siemens Healthineers AG are some of the major industry contenders.